Lantheus Holdings, Inc.

Lantheus Holdings, Inc. is not very popular among insiders. Lantheus Holdings, Inc. is a good stock to invest in, but there are better stocks to choose.
Log in to see more information.
Lantheus Holdings, Inc. engages in the development, manufacture and commercialization of diagnostic...

News

Lantheus Holdings (NASDAQ:LNTH) pulls back 4.2% this week, but still delivers shareholders massive 60% CAGR over 3 years
Lantheus Holdings (NASDAQ:LNTH) pulls back 4.2% this week, but still delivers shareholders massive 60% CAGR over 3 years

Simply Wall St Research Lantheus Holdings' (Nasdaq:LNTH) stock price, latest news & stock analysis. Find everything from its Valuation, Future Growth, Past Performance and more.\n more…

Lantheus Appoints Julie Eastland as New Board Member
Lantheus Appoints Julie Eastland as New Board Member

Globe Newswire BEDFORD, Mass., Sept. 05, 2024 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. ( Lantheus ) (NASDAQ: LNTH), the leading radiopharmaceutical-focused company committed to enabling clinicians to Find...\n more…

Bargain Hunting for Stocks: 2 Stocks to Buy in September
Bargain Hunting for Stocks: 2 Stocks to Buy in September

Fool.com Headlines In this video, Motley Fool contributors Jason Hall and Tyler Crowe break down why PayPal (NASDAQ: PYPL) and Lantheus Holdings (NASDAQ: LNTH) are bargain stocks worth buying now.*Stock prices used...\n more…

Lantheus to Present at the Morgan Stanley 22nd Annual Global Healthcare Conference
Lantheus to Present at the Morgan Stanley 22nd Annual Global Healthcare Conference

Globe Newswire BEDFORD, Mass., Aug. 28, 2024 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. ( Lantheus ) (NASDAQ: LNTH), the leading radiopharmaceutical-focused company committed to enabling clinicians to Find...\n more…

Are Strong Financial Prospects The Force That Is Driving The Momentum In Lantheus Holdings, Inc.'s NASDAQ:LNTH) Stock?
Are Strong Financial Prospects The Force That Is Driving The Momentum In Lantheus Holdings, Inc.'s NASDAQ:LNTH) Stock?

Simply Wall St Lantheus Holdings (NASDAQ:LNTH) has had a great run on the share market with its stock up by a significant 31% over the...\n more…

Lantheus to Present Additional Clinical Data from Phase 3 Pivotal SPLASH Trial in PSMA-Positive Metastatic Castration-Resistant Prostate Cancer During ESMO Congress 2024
Lantheus to Present Additional Clinical Data from Phase 3 Pivotal SPLASH Trial in PSMA-Positive Metastatic Castration-Resistant Prostate Cancer During ESMO Congress 2024

Globe Newswire BEDFORD, Mass., Aug. 20, 2024 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. ( Lantheus ) (NASDAQ: LNTH), the leading radiopharmaceutical-focused company committed to enabling clinicians to Find...\n more…